N

    Nutriband Inc (NTRB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.34
    -0.12 (-2.69%)

    Market Cap: $54.22M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    32%(8/25)
    Avg Surprise
    -173.21%
    Streak
    3 Q

    Upcoming Estimates

    Jul 31, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $0
    Range$0 - $0
    0 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Jul 26EST
    		-N/A---
    Apr 26
    		$-0.08N/A+95.79%Beat+33.7%
    Jan 26
    		$-0.04N/A+97.88%Beat+92.2%
    Oct 25
    		$-0.32N/A+84.98%Beat-160.8%
    Jul 25
    		$-2.12$-0.17-1147.06%Miss-1274.8%
    Apr 25
    		$-0.12$-0.16+25.00%Beat+42.1%
    Jan 25
    		$-0.51$-0.12-325.00%Miss-122.2%
    Oct 24
    		$-0.12N/AN/ABeat+45.4%
    Jul 24
    		$-0.15$0.00N/ABeat-45.6%
    Apr 24
    		$-0.21$0.00N/ABeat-59.9%
    Jan 24
    		$-0.23N/AN/ABeat-35.0%
    Oct 23
    		$-0.22$-0.06-274.50%Miss-60.5%
    Jul 23
    		$-0.11$-0.07-51.29%Miss+11.8%
    Apr 23
    		$-0.13$-0.06-116.00%Miss-62.0%
    Jan 23
    		$-0.17$-0.05-240.00%Miss+63.0%
    Oct 22
    		$-0.14$-0.07-100.00%Miss+39.1%
    Jul 22
    		$-0.12$-0.07-71.43%Miss-71.4%
    Apr 22
    		$-0.08$-0.06-33.33%Miss-60.0%
    Jan 22
    		$-0.46$-0.09-411.11%Miss-39.4%
    Oct 21
    		$-0.23$-0.03-666.67%Miss-2200.0%
    Jul 21
    		$-0.07$0.01-800.00%Miss-133.3%
    Apr 21
    		$-0.05$-0.05+0.00%Beat+82.1%
    Jan 21
    		$-0.33$0.00N/AMiss-200.0%
    Oct 20
    		$-0.01N/A+66.67%Beat+80.0%
    Jul 20
    		$-0.03$-0.06+50.00%Beat+57.1%
    Apr 20
    		$-0.28$-0.11-154.55%Miss-180.0%
    Jan 20
    		$-0.11$-0.08-37.50%Miss-37.5%
    Oct 19
    		$-0.05$-0.08+37.50%Beat+28.6%
    Jul 19
    		$-0.07$-0.06-16.67%Miss+80.6%
    Apr 19
    		$-0.10$-0.07-42.86%Miss+0.0%
    Jan 19
    		$-0.08$0.04-300.00%Miss+80.0%
    Oct 18
    		$-0.07N/AN/ABeat-
    Jul 18
    		$-0.36N/AN/ABeat-
    Apr 18
    		$-0.10N/AN/ABeat-
    Jan 18
    		$-0.40N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-1.70EV/EBITDA-4.56x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-289.40%
    ROE-145.70%ROIC-104.60%
    Financial Health
    Debt/Equity0.03xInterest Coverage-375.82x
    Current Ratio5.26xQuick Ratio5.11x
    Trading Statistics
    Beta1.97Avg Volume26.91K
    52-Week High$8.6352-Week Low$2.80

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.33
    SMA 20$3.71
    SMA 50$3.30
    SMA 200$3.97
    EMA 10$4.27
    EMA 20$3.92
    EMA 50$3.56
    EMA 200$4.06

    MACD

    Line: 0.41Signal: 0.32Hist: 0.09

    ADX

    ADX: 41.8+DI: 40.3-DI: 16.6

    Aroon & PSAR

    Aroon Up80.0
    Aroon Down28.0
    PSAR$5.57

    Bollinger Bands

    Upper Band$5.21
    Lower Band$2.21
    %B Position8106%(Upper)
    Band Width0.71

    RSI (14-Day)

    Neutral
    62.4

    Momentum Oscillators

    Stoch %K54.2
    Stoch %D58.0
    Williams %R-51.1
    ROC (10d)34.4%
    Momentum1.11
    CCI (20d)65.8
    MFI (14d)74.3

    Volatility Measures

    ATR (14d)$0.32(7.4%)
    StdDev (20d)0.75
    Hist Vol101.8%(High)

    Volume Flow

    VWAP$4.34
    OBV6.5M
    AD Line-26.4M
    CMF (20d)0.093

    Volume Metrics

    Avg Vol (20d)28.0K
    Vol Ratio0.9x
    VWMA (20d)$4.62

    Pivot Points

    R3$4.94
    R2$4.83
    R1$4.65
    Pivot Point$4.54
    S1$4.35
    S2$4.24
    S3$4.06

    Advanced Oscillators

    TSI39.69
    Ultimate Osc56.7
    KST395.59

    Financial Data

    QuarterApr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023Jul 2023
    Total Revenue$433,399$400,709$346,058$622,452$667,432$642,379$645,796$442,830$408,532$524,613$427,841$442,830
    Cost of Revenue$236,598$311,768$277,553$465,571$415,451$367,757$454,767$352,012$243,746$343,385$268,920$341,272
    Gross Profit$196,801$88,941$68,505$156,881$251,981$274,622$191,029$90,818$164,786$181,228$158,921$101,558
    Operating Expenses$1.45M$1.11M$3.95M$2.16M$1.67M$2.24M$1.62M$1.50M$2.05M$1.83M$1.88M$1.51M
    R&D$247,261$188,036$457,113$562,554$683,426$489,856$880,768$773,975$974,535$563,370$551,503$773,975
    SG&A$1.20M$921,820$3.49M$1.60M$982,052$1.76M$737,102$737,325$1.08M$924,207$1.33M$737,325
    Operating Income$-1,254,351$-1,020,915$-3,880,336$-2,003,213$-1,413,497$-1,964,000$-1,426,841$-1,410,000$-1,889,477$-1,306,349$-1,723,511$-1,409,742
    Interest Income$0$58,190$13,517$8,649$0$46,084$68,235$77,332$18$3,020$3,765$77,332
    Interest Expense$5,008$5,334$5,548$5,773$5,880$3,739$4,031$5,019$8,618$23,214$40,200$373,055
    Income Before Tax$-1,241,956$-968,059$-3,872,367$-2,000,337$-1,388,869$-5,516,000$-1,362,637$-1,705,000$-1,898,077$-1,880,966$-1,759,946$-1,705,465
    Income Tax Expense$0$0$0$0$0$0$0$1$0$0$0$0
    Net Income$-1,241,956$-968,059$-3,872,367$-2,000,337$-1,388,869$-5,516,000$-1,362,637$-1,705,000$-1,898,077$-1,880,966$-1,759,946$-1,705,465
    EBITDA$-1,202,771$-985,036$-3,837,280$-1,945,831$-1,325,509$-5,440,000$-1,426,841$-1,630,000$-1,820,376N/A$-1,644,179$-1,409,742
    EBIT$-1,236,948$-1,020,915$-3,880,336$-2,003,213$-1,382,989$-5,512,853$-1,426,841$-1,699,949$-1,889,477$-1,306,349$-1,723,511$-1,409,742
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NTRB

    News

    Nutriband (NTRB) Stock Forum and Discussion

    This article provides a forum and discussion platform for Nutriband (NTRB) stock. It serves as a space for investors and interested parties to exchange information and opinions regarding the company's stock performance and related news.

    Moomoo•8/25/26•
    Neutral

    Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight

    Nutriband Inc. CEO and Co-Founder, Gareth Sheridan, will present at the 2026 Georgia Life Sciences Summit on August 26th as part of the CEO spotlight event. The summit gathers leaders in biotechnology, medical technology, research, manufacturing, and investment to highlight Georgia's growing role in life sciences innovation. Nutriband is developing transdermal pharmaceutical products, including an abuse-deterrent fentanyl patch using its AVERSA™ technology.

    GlobeNewswire•8/14/26•
    Somewhat-Bullish

    Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight

    Nutriband Inc. announced that its CEO and Co-Founder, Gareth Sheridan, will present at the 2026 Georgia Life Sciences Summit on August 26th. The summit brings together leaders in life sciences to showcase Georgia's innovation in biotechnology, medical technology, research, manufacturing, and investment. Nutriband's presentation will be part of the CEO spotlight event.

    Yahoo Finance•8/13/26•
    Somewhat-Bullish

    Nutriband Inc (NTRB) Earnings Forecast: Future EPS & Revenue Growth Estimates

    The article provides an earnings forecast for Nutriband Inc (NTRB), indicating a current earnings forecast score of 8.00 and an average price target of $15.00 based on one analyst. The analyst recommends a "Buy" rating for NTRB, suggesting a potential upside of over 370%.

    TradingKey•8/8/26•
    Bullish

    Nutriband Inc (NTRB) Stock News Today

    This article provides current stock news for Nutriband Inc (NTRB), indicating a slight dip in its stock price and market capitalization. It highlights that more news and updates, including earnings and analyst ratings, are expected soon. The page serves as a hub for investors to track NTRB's performance and related developments.

    TradingKey•8/7/26•
    Neutral

    Frequently Asked Questions About NTRB

    Does NTRB pay dividends?
    Nutriband Inc (NTRB) does not currently pay a regular dividend.
    What is NTRB's market cap?
    Nutriband Inc (NTRB) has a market capitalization of $54.22M with a current stock price of $4.34.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In